News & Analysis on Clinical Trial Services & Contract Research And Development
BioPartners, currently leading the line amongst companies trying to bring copies of off-patent biologic drugs to the European market, has licensed a needle-free delivery technology for its human growth hormone (hGH) product.
US company Codexis has acquired Germany's Juelich Fine Chemicals, one of Europe's leading producers of specialty enzymes or biocatalysts for the production of chiral pharmaceutical intermediates.
Worldwide demand for packaging equipment for the pharmaceutical and personal care products sector is forecast to post the strongest gains of any market through 2008, reaching $4.4 billion in that year.
A consortium of companies producing biodegradable and compostable polymers for packaging has committed itself to guaranteeing an efficient biodegradeability standard across the EU.
Agilent Technologies has introduced the first high-performance liquid chromatography (HPLC)-chip/mass spectrometry (MS) system for protein identification. This breakthrough microfluidics-based LC/MS technology is expected to significantly increase the...
Japanese company GSI Creos has unveiled the first prototype of a new cell culture reactor that uses nanotechnology to support the growth of more cells than conventional reactors. The bioreactor could potentially boost the yield of biological drugs...